Kalbe Farma Tbk PT
PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biop… Read more
Kalbe Farma Tbk PT (KLBF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.040x
Based on the latest financial reports, Kalbe Farma Tbk PT (KLBF) has a cash flow conversion efficiency ratio of 0.040x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp956.75 Billion) by net assets (Rp24.19 Trillion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Kalbe Farma Tbk PT - Cash Flow Conversion Efficiency Trend (2000–2024)
This chart illustrates how Kalbe Farma Tbk PT's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Kalbe Farma Tbk PT Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kalbe Farma Tbk PT ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Motherson Sumi Wiring India Limited
NSE:MSUMI
|
0.041x |
|
ECMPF
PINK:ECMPF
|
0.008x |
|
MIPS AB (publ)
OTCGREY:MPZAF
|
0.076x |
|
Couchbase Inc
NASDAQ:BASE
|
-0.028x |
|
An Hui Wenergy Co Ltd
SHE:000543
|
0.133x |
|
GigaCloud Technology Inc Class A Ordinary Shares
NASDAQ:GCT
|
0.132x |
|
Shenzhen Microgate Technology Co Ltd
SHE:300319
|
0.060x |
|
Vizsla Silver Corp.
TO:VZLA
|
-0.003x |
Annual Cash Flow Conversion Efficiency for Kalbe Farma Tbk PT (2000–2024)
The table below shows the annual cash flow conversion efficiency of Kalbe Farma Tbk PT from 2000 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Rp24.59 Trillion | Rp4.79 Trillion | 0.195x | +54.74% |
| 2023-12-31 | Rp23.12 Trillion | Rp2.91 Trillion | 0.126x | -26.28% |
| 2022-12-31 | Rp22.10 Trillion | Rp3.77 Trillion | 0.171x | +28.37% |
| 2021-12-31 | Rp21.27 Trillion | Rp2.83 Trillion | 0.133x | -42.38% |
| 2020-12-31 | Rp18.28 Trillion | Rp4.21 Trillion | 0.231x | +53.92% |
| 2019-12-31 | Rp16.71 Trillion | Rp2.50 Trillion | 0.150x | -17.30% |
| 2018-12-31 | Rp15.29 Trillion | Rp2.77 Trillion | 0.181x | +25.33% |
| 2017-12-31 | Rp13.89 Trillion | Rp2.01 Trillion | 0.145x | -16.59% |
| 2016-12-31 | Rp12.46 Trillion | Rp2.16 Trillion | 0.173x | -22.85% |
| 2015-12-31 | Rp10.94 Trillion | Rp2.46 Trillion | 0.225x | -4.79% |
| 2014-12-31 | Rp9.82 Trillion | Rp2.32 Trillion | 0.236x | +116.28% |
| 2013-12-31 | Rp8.50 Trillion | Rp927.16 Billion | 0.109x | -41.58% |
| 2012-12-31 | Rp7.37 Trillion | Rp1.38 Trillion | 0.187x | -17.44% |
| 2011-12-31 | Rp6.52 Trillion | Rp1.47 Trillion | 0.226x | +13.15% |
| 2010-12-31 | Rp5.77 Trillion | Rp1.15 Trillion | 0.200x | -29.78% |
| 2009-12-31 | Rp4.79 Trillion | Rp1.36 Trillion | 0.285x | +53.10% |
| 2008-12-31 | Rp4.34 Trillion | Rp807.70 Billion | 0.186x | +105.77% |
| 2007-12-31 | Rp4.02 Trillion | Rp362.90 Billion | 0.090x | -50.02% |
| 2006-12-31 | Rp3.54 Trillion | Rp640.61 Billion | 0.181x | +15.14% |
| 2005-12-31 | Rp2.81 Trillion | Rp441.37 Billion | 0.157x | -45.36% |
| 2004-12-31 | Rp1.48 Trillion | Rp425.07 Billion | 0.287x | -42.02% |
| 2003-12-31 | Rp1.02 Trillion | Rp507.17 Billion | 0.496x | -19.13% |
| 2002-12-31 | Rp651.41 Billion | Rp399.13 Billion | 0.613x | +25.47% |
| 2001-12-31 | Rp345.97 Billion | Rp168.95 Billion | 0.488x | +52.08% |
| 2000-12-31 | Rp305.74 Billion | Rp98.17 Billion | 0.321x | -- |